Use of Mutants in the Study of Aminocyclitol Antibiotic Biosynthesis and the Preparation of the Hybrimycin C Complex

W. Thomas Shier, Phillip C. Schaefer, David Gottlieb, Kenneth L. Rinehart

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

A technique previously used to isolate a mutant of Streptomyces fradiae capable of synthesizing the antibiotic neomycin only in the presence of the subunit 2-deoxystreptamine has been applied to S. rimosus forma paromomycinus and S. kanamyceticus to produce mutants capable of synthesizing paromomycin and kanamycin, respectively, only in the presence of added 2-deoxystreptamine subunit. Neamine, paromamine, and 6-kanosaminido-2-deoxystreptamine—2-deoxystreptamine-containing glycosides that are plausible intermediates in the biosynthesis of the three antibiotics—were also tested as substrates. The mutants studied did not convert the glycosides to active antibiotics. The mutant of 5. rimosus forma paromomycinus converts streptamine, an analog of 2-deoxystreptamine, to two new antibiotics, hybrimycins C1 and C2, analogs of paromomycins I and II, respectively, in which the only modification is that 2-deoxystreptamine has been replaced by streptamine. Selective hydrolysis yielded a third new antibiotic, hybrimycin C3, an analog of paromamine.

Original languageEnglish (US)
Pages (from-to)5073-5078
Number of pages6
JournalBiochemistry
Volume13
Issue number25
DOIs
StatePublished - Dec 1 1974

Fingerprint

Biosynthesis
Anti-Bacterial Agents
Paromomycin
Glycosides
Kanamycin
Neomycin
Streptomyces
Hydrolysis
Hybrimycins
2-deoxystreptamine
Substrates
streptamine
paromamine

Cite this

Use of Mutants in the Study of Aminocyclitol Antibiotic Biosynthesis and the Preparation of the Hybrimycin C Complex. / Shier, W. Thomas; Schaefer, Phillip C.; Gottlieb, David; Rinehart, Kenneth L.

In: Biochemistry, Vol. 13, No. 25, 01.12.1974, p. 5073-5078.

Research output: Contribution to journalArticle

Shier, W. Thomas ; Schaefer, Phillip C. ; Gottlieb, David ; Rinehart, Kenneth L. / Use of Mutants in the Study of Aminocyclitol Antibiotic Biosynthesis and the Preparation of the Hybrimycin C Complex. In: Biochemistry. 1974 ; Vol. 13, No. 25. pp. 5073-5078.
@article{d72411f4129646a4a7e0c63585559218,
title = "Use of Mutants in the Study of Aminocyclitol Antibiotic Biosynthesis and the Preparation of the Hybrimycin C Complex",
abstract = "A technique previously used to isolate a mutant of Streptomyces fradiae capable of synthesizing the antibiotic neomycin only in the presence of the subunit 2-deoxystreptamine has been applied to S. rimosus forma paromomycinus and S. kanamyceticus to produce mutants capable of synthesizing paromomycin and kanamycin, respectively, only in the presence of added 2-deoxystreptamine subunit. Neamine, paromamine, and 6-kanosaminido-2-deoxystreptamine—2-deoxystreptamine-containing glycosides that are plausible intermediates in the biosynthesis of the three antibiotics—were also tested as substrates. The mutants studied did not convert the glycosides to active antibiotics. The mutant of 5. rimosus forma paromomycinus converts streptamine, an analog of 2-deoxystreptamine, to two new antibiotics, hybrimycins C1 and C2, analogs of paromomycins I and II, respectively, in which the only modification is that 2-deoxystreptamine has been replaced by streptamine. Selective hydrolysis yielded a third new antibiotic, hybrimycin C3, an analog of paromamine.",
author = "Shier, {W. Thomas} and Schaefer, {Phillip C.} and David Gottlieb and Rinehart, {Kenneth L.}",
year = "1974",
month = "12",
day = "1",
doi = "10.1021/bi00722a002",
language = "English (US)",
volume = "13",
pages = "5073--5078",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "25",

}

TY - JOUR

T1 - Use of Mutants in the Study of Aminocyclitol Antibiotic Biosynthesis and the Preparation of the Hybrimycin C Complex

AU - Shier, W. Thomas

AU - Schaefer, Phillip C.

AU - Gottlieb, David

AU - Rinehart, Kenneth L.

PY - 1974/12/1

Y1 - 1974/12/1

N2 - A technique previously used to isolate a mutant of Streptomyces fradiae capable of synthesizing the antibiotic neomycin only in the presence of the subunit 2-deoxystreptamine has been applied to S. rimosus forma paromomycinus and S. kanamyceticus to produce mutants capable of synthesizing paromomycin and kanamycin, respectively, only in the presence of added 2-deoxystreptamine subunit. Neamine, paromamine, and 6-kanosaminido-2-deoxystreptamine—2-deoxystreptamine-containing glycosides that are plausible intermediates in the biosynthesis of the three antibiotics—were also tested as substrates. The mutants studied did not convert the glycosides to active antibiotics. The mutant of 5. rimosus forma paromomycinus converts streptamine, an analog of 2-deoxystreptamine, to two new antibiotics, hybrimycins C1 and C2, analogs of paromomycins I and II, respectively, in which the only modification is that 2-deoxystreptamine has been replaced by streptamine. Selective hydrolysis yielded a third new antibiotic, hybrimycin C3, an analog of paromamine.

AB - A technique previously used to isolate a mutant of Streptomyces fradiae capable of synthesizing the antibiotic neomycin only in the presence of the subunit 2-deoxystreptamine has been applied to S. rimosus forma paromomycinus and S. kanamyceticus to produce mutants capable of synthesizing paromomycin and kanamycin, respectively, only in the presence of added 2-deoxystreptamine subunit. Neamine, paromamine, and 6-kanosaminido-2-deoxystreptamine—2-deoxystreptamine-containing glycosides that are plausible intermediates in the biosynthesis of the three antibiotics—were also tested as substrates. The mutants studied did not convert the glycosides to active antibiotics. The mutant of 5. rimosus forma paromomycinus converts streptamine, an analog of 2-deoxystreptamine, to two new antibiotics, hybrimycins C1 and C2, analogs of paromomycins I and II, respectively, in which the only modification is that 2-deoxystreptamine has been replaced by streptamine. Selective hydrolysis yielded a third new antibiotic, hybrimycin C3, an analog of paromamine.

UR - http://www.scopus.com/inward/record.url?scp=0016287808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016287808&partnerID=8YFLogxK

U2 - 10.1021/bi00722a002

DO - 10.1021/bi00722a002

M3 - Article

VL - 13

SP - 5073

EP - 5078

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 25

ER -